Join
Live feed
·
PRReleasevia Quantisnow
FibroBiologics Inc. logo

FibroBiologics Announces Issuance of New U.S. Patent for the Treatment of Degenerative Disc Disease Using Fibroblast Conditioned Media

ByQuantisnow·Wall Street's wire, on your screen.
FBLG· FibroBiologics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FBLG (FibroBiologics Inc.) and more on Quantisnow.